Huguet et al., 2004 - Google Patents
Extracorporeal adsorption of anti-factor VIII allo-antibodies on randomly functionalized polystyrene resinsHuguet et al., 2004
- Document ID
- 3986840683911539420
- Author
- Huguet H
- Lasne D
- Rothschild C
- Siali R
- Jozefonvicz J
- Publication year
- Publication venue
- Thrombosis and haemostasis
External Links
Snippet
The occurrence of anti-factor VIII (FVIII) allo-antibodies is a severe complication of the treatment of haemophilia A patients, leading to the inhibition of transfused FVIII activity. The effective elimination of these inhibitory antibodies plays a decisive role in the management …
- 108010067319 Isoantibodies 0 title abstract description 9
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kim et al. | Purified factor IX using monoclonal immunoaffinity technique: clinical trials in hemophilia B and comparison to prothrombin complex concentrates | |
| JP4250770B2 (en) | Purification of von Willebrand factor by cation exchange chromatography. | |
| JPH07238034A (en) | Viii: pharmaceutical preparation c | |
| JP3963406B2 (en) | Purification method of factor VII and activation factor VIIa | |
| JPH0638790A (en) | Specific monoclonal antibody against factor- viii:c coagulation factor polypeptides | |
| Nilsson et al. | Noncoagulation inhibitory factor VIII antibodies after induction of tolerance to factor VIII in hemophilia A patients | |
| US4831119A (en) | Preparation for the treatment of hemophilia A inhibitor patients and a process for producing such a preparation | |
| Huguet et al. | Extracorporeal adsorption of anti-factor VIII allo-antibodies on randomly functionalized polystyrene resins | |
| Yavuz et al. | Immunoadsorption of cholesterol on protein A oriented beads | |
| AU747274B2 (en) | Improved methods for producing factor VIII proteins | |
| Tharakan et al. | Development of an immunoaffinity process for factor IX purification | |
| Boisson‐Vidal et al. | Polystyrene derivatives as candidates for extracorporeal adsorption of Factor VIII antibodies in the management of haemophiliac patients | |
| Mori et al. | Progress in large‐scale purification of factor VIII/von Willebrand factor concentrates using ion‐exchange chromatography | |
| Hosseini et al. | Preparation of factor VII concentrate using CNBr-activated Sepharose 4B immunoaffinity chromatography | |
| Theodorsson et al. | A technique for specific removal of factor IX alloantibodies from human plasma: partial characterization of the alloantibodies | |
| Dahri et al. | Synthetic sorbents for removal of factor VIII inhibitors from haemophilic A plasma | |
| JP2010532337A (en) | Use of a chromatographic support to reduce the amount of ADAMTS13 in solution from plasma | |
| Boisson-Vidal et al. | Polystyrene derivatives as candidates for extracorporeal adsorption of anti-Factor VIII antibodies in the management of haemophiliac patients | |
| Regnault et al. | A potential new procedure for removing anti-factor VIII antibodies from hemophilic plasma | |
| Regnault et al. | Monoclonal antibodies against human plasma protein C and their uses for immunoaffinity chromatography | |
| Tran et al. | Rabbit antibodies against the procoagulant activity (VIII: C) of human factor VIII | |
| CA2446390C (en) | Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof | |
| Te Booy et al. | Affinity purification of plasma proteins: characterization of six affinity matrices and their application for the isolation of human factor VIII | |
| Horowitz et al. | Purification of low molecular weight factor VIII by affinity chromatography using factor VIII-sepharose | |
| Yoshioka et al. | A simple method for analyzing factor IX activation in the patients with hemophilia B variants |